DarioHealth Corp.
DRIO Healthcare Health Information Services
DarioHealth Corp.’s revenue for fiscal 2025 (year ended December 2025) was $22.4 million, down 17.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.58%, EPS grew 76.4%, free cash flow was flat and total debt rose 1.85%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow DRIO
DarioHealth Corp. (DRIO) Beneish M-score
DarioHealth Corp.'s Beneish M-score for fiscal 2025 is −3.58; values above −1.78 are the model's flag for possible earnings manipulation — a statistical screen, not a finding.
Beneish M-score, annual
Embed this chart
Annual newest first
| Period | Beneish M-score | Change (points) |
|---|---|---|
| FY2025 | −3.58 | (1.24) |
| FY2024 | −2.34 | 1.86 |
| FY2023 | −4.20 | (1.55) |
| FY2022 | −2.65 | (10.97) |
| FY2021 | 8.32 | 10.60 |
| FY2020 | −2.28 | (0.50) |
| FY2019 | −1.77 | 2.06 |
| FY2018 | −3.84 | 2.69 |
| FY2017 | −6.52 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Days’ sales in receivables index | 0.76 | — | 0.70 | |
| Gross margin index | 0.87 | — | 0.46 | |
| Asset quality index | 1.04 | — | 0.42 | |
| Sales growth index | 0.83 | — | 0.74 | |
| Depreciation index | 1.07 | — | 0.12 | |
| SG&A index | 0.92 | — | −0.16 | |
| Total accruals to total assets | (0.14) | — | −0.67 | |
| Leverage index | 1.08 | — | −0.35 | |
| Beneish M-score | Low — no pattern the model associates with manipulation | −3.58 | ||
How the Beneish M-score works
M = −4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI (Beneish, 1999): eight changes in the accounts from one fiscal year to the next, which the model weighs for the pattern seen in companies that later restated their earnings. Higher is worse.
| below −2.22 | Low — no pattern the model associates with manipulation |
|---|---|
| −2.22 to −1.78 | Elevated |
| above −1.78 | Flagged by the model |
−1.78 is the cut-off usually quoted from the paper, −2.22 a common conservative one. A statistical screen, not a finding of wrongdoing.
When asset quality, depreciation or SG&A cannot be worked out, that index is set to 1, as Beneish did, and the breakdown says so; with all three missing there is no score. Depreciation includes amortisation, and asset quality leaves out securities. Not worked out for banks, insurers and REITs.
Beneish M-score against peers
| Company | Beneish M-score |
|---|---|
| RNLXY Renalytix plc - Sponsored ADR compare | −4.7× |
| DH Definitive Healthcare Corp. compare | −4.2× |
| HCAT Health Catalyst, Inc. compare | −3.9× |
| LFMD LifeMD, Inc. compare | −3.7× |
| DRIO DarioHealth Corp. | −3.6× |
| CCLD CareCloud, Inc. compare | −3.3× |
| OPRX OptimizeRx Corp. compare | −2.8× |
| ONMD OneMedNet Corporation compare | — |
| BEAT HeartBeam, Inc. compare | — |
What Beneish M-score is
The Beneish M-Score combines eight year-on-year changes in the accounts into a statistical screen for patterns seen in companies that overstated earnings.
−4.84 + 0.920 × DSRI + 0.528 × GMI + 0.404 × AQI + 0.892 × SGI + 0.115 × DEPI − 0.172 × SGAI + 4.679 × TATA − 0.327 × LVGI